SCHEMBL25199373

SCHEMBL25199373

CCC1C(F)C(O)CC1(NC(=O)c1ccccc1)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.51
CYP2C19 P33261 1/20 0.51
FAAH O00519 2/20 0.45
P2RX7 Q99572 1/20 0.39
EPHX1 P07099 1/20 0.38
HSD17B10 Q99714 3/20 0.36
ADRB2 P07550 1/20 0.36
CNR2 P34972 2/20 0.36
CTSL P07711 1/20 0.35
LPAR1 Q92633 1/20 0.35
GRM2 Q14416 1/20 0.34
GRM3 Q14832 1/20 0.34
CTSK P43235 1/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
POLB P06746 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
APAF1 O14727 1/20 0.34
TDP2 O95551 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23833806 0.80 MAPK1 (0.44) MAPK1CYP2C19FAAHP2RX7HSD17B10
SCHEMBL1740252 0.77 MAPK1 (0.60) MAPK1CYP2C19FAAHP2RX7EPHX1
Benzoic Acid SCHEMBL1739284 0.74 MAPK1 (0.56) MAPK1CYP2C19FAAHP2RX7EPHX1
SCHEMBL7417055 0.68 MAPK1 (1.00) MAPK1CYP2C19FAAHP2RX7EPHX1
SCHEMBL23833796 0.68 MAPK1 (0.48) MAPK1CYP2C19FAAHP2RX7EPHX1
SCHEMBL25265200 0.67 ALDH1A1 (0.35) HSD17B10ALDH1A1KDM4EMEN1HTT
SCHEMBL25199371 0.66 HSD17B10 (0.42) MAPK1CYP2C19FAAHHSD17B10CTSL
SCHEMBL8022535 0.63 CYP2C19 (0.52) MAPK1CYP2C19FAAHALDH1A1MAPT
SCHEMBL8018575 0.63 MAPK1 (0.52) MAPK1CYP2C19FAAHGRM2GRM3
SCHEMBL1421026 0.63 FAAH (1.00) FAAHEPHX1HSD17B10CNR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230158178-A1 Radionuclide Tracers of 1-Amino-3,4-Difluorocyclopentane-1-Carboxylic Acid, Derivatives, and Uses Thereof UNIV EMORY (US) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230158178-A1 Radionuclide Tracers of 1-Amino-3,4-Difluorocyclopentane-1-Carboxylic Acid, Derivatives, and Uses Thereof AFF1, METTL3, VHL MAPK1 3027/4885CYP2C19 2519/4885FAAH 438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.